Semler Scientific (SMLR) Competitors $45.97 +3.65 (+8.62%) Closing price 07/10/2025 04:00 PM EasternExtended Trading$47.32 +1.35 (+2.94%) As of 04:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMLR vs. CNMD, AORT, CDRE, TNDM, ESTA, LQDA, SSII, FNA, BLFS, and PLSEShould you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include CONMED (CNMD), Artivion (AORT), Cadre (CDRE), Tandem Diabetes Care (TNDM), Establishment Labs (ESTA), Liquidia Technologies (LQDA), SS Innovations International (SSII), Paragon 28 (FNA), BioLife Solutions (BLFS), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry. Semler Scientific vs. Its Competitors CONMED Artivion Cadre Tandem Diabetes Care Establishment Labs Liquidia Technologies SS Innovations International Paragon 28 BioLife Solutions Pulse Biosciences Semler Scientific (NASDAQ:SMLR) and CONMED (NYSE:CNMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment. Is SMLR or CNMD more profitable? CONMED has a net margin of 9.02% compared to Semler Scientific's net margin of -60.69%. Semler Scientific's return on equity of 19.75% beat CONMED's return on equity.Company Net Margins Return on Equity Return on Assets Semler Scientific-60.69% 19.75% 15.47% CONMED 9.02%14.36%5.86% Do analysts rate SMLR or CNMD? Semler Scientific presently has a consensus price target of $89.00, indicating a potential upside of 93.60%. CONMED has a consensus price target of $62.20, indicating a potential upside of 16.11%. Given Semler Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Semler Scientific is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Do institutionals and insiders have more ownership in SMLR or CNMD? 49.4% of Semler Scientific shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by company insiders. Comparatively, 3.1% of CONMED shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings and valuation, SMLR or CNMD? CONMED has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemler Scientific$56.29M11.18$40.90M-$2.61-17.61CONMED$1.31B1.27$132.42M$3.8014.10 Does the media refer more to SMLR or CNMD? In the previous week, Semler Scientific had 9 more articles in the media than CONMED. MarketBeat recorded 16 mentions for Semler Scientific and 7 mentions for CONMED. CONMED's average media sentiment score of 0.91 beat Semler Scientific's score of 0.27 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Semler Scientific 2 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral CONMED 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, SMLR or CNMD? Semler Scientific has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, CONMED has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. SummarySemler Scientific beats CONMED on 11 of the 17 factors compared between the two stocks. Get Semler Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMLR vs. The Competition Export to ExcelMetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$579.29M$6.75B$5.55B$9.04BDividend YieldN/A1.26%5.25%4.04%P/E Ratio-17.6125.5427.2020.14Price / Sales11.1870.83413.3398.20Price / Cash9.4620.8037.5058.41Price / Book1.854.778.085.60Net Income$40.90M$174.76M$3.16B$248.43M7 Day Performance15.79%1.56%4.68%5.47%1 Month Performance44.92%-0.05%4.49%7.87%1 Year Performance36.73%10.46%30.99%18.75% Semler Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMLRSemler Scientific2.4257 of 5 stars$45.97+8.6%$89.00+93.6%+41.9%$579.29M$56.29M-17.61120Analyst ForecastHigh Trading VolumeCNMDCONMED4.7046 of 5 stars$52.10-0.1%$62.20+19.4%-17.9%$1.61B$1.31B13.713,900AORTArtivion2.7067 of 5 stars$31.17-0.1%$32.00+2.7%+25.2%$1.33B$388.54M-62.341,600CDRECadre3.2734 of 5 stars$31.94-0.3%$37.50+17.4%-6.6%$1.30B$567.56M33.622,284TNDMTandem Diabetes Care4.1754 of 5 stars$18.64-1.6%$33.43+79.3%-63.5%$1.26B$940.20M-6.712,650Positive NewsAnalyst ForecastESTAEstablishment Labs1.6316 of 5 stars$42.71+4.3%$52.40+22.7%+6.1%$1.18B$166.02M-13.781,018Analyst ForecastLQDALiquidia Technologies3.2628 of 5 stars$12.46-4.9%$26.89+115.8%+13.2%$1.12B$14M-7.8950SSIISS Innovations InternationalN/A$5.89+2.1%N/AN/A$1.12B$20.65M0.004News CoverageFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+92.9%$1.10B$256.18M-17.71343,000High Trading VolumeBLFSBioLife Solutions2.9128 of 5 stars$21.54+0.2%$31.17+44.7%+17.7%$1.02B$82.25M-74.27440High Trading VolumePLSEPulse Biosciences3.8984 of 5 stars$15.09+0.1%N/A+15.2%$1.01B$700K0.00140 Related Companies and Tools Related Companies CONMED Alternatives Artivion Alternatives Cadre Alternatives Tandem Diabetes Care Alternatives Establishment Labs Alternatives Liquidia Technologies Alternatives SS Innovations International Alternatives Paragon 28 Alternatives BioLife Solutions Alternatives Pulse Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMLR) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMLR Stock Alerts